Empowering Hospitals, Innovators, and Investors Across Every Sector
The DarrowEverett Health Care & Life Sciences Practice advises clients across the heavily regulated and consistently evolving health care and life sciences industry. Service providers including hospitals; facilities; manufacturers; suppliers; lenders; investors; academia; and healthcare technology, biotechnology, food and dietary supplement, insurance, medical device, and pharmaceutical companies turn to us for assistance with the myriad of legal and regulatory issues and challenges that they face day to day in their businesses.
The DE team has extensive experience in healthcare mergers, acquisitions, joint ventures; strategic positioning, restructuring, capital access, private equity investments, divestitures, and bankruptcies. We aid with licensing, tax issues, government investigations, employment matters, governance, regulatory compliance, and Medicare/Medicaid reimbursement disputes and have litigated complex disputes involving commercial transactions and allegations of fraud, anti-kickback, and false claims act violations.
Our clients that manufacture or market products regulated by the US Food and Drug Administration (FDA) must also deal with the constantly changing procedural, regulatory, and legislative matters surrounding compliance, enforcement and product development, approvals, launch, sales, and marketing, reporting obligations, disclosures, and recalls.
The DE Health Care Practice Group regularly advises clients on:
Contact Us to Ensure Compliance and Protect Your Business
Let us know how DarrowEverett can serve your organization.
Practice Leaders
DE Insights
Our team wants you to stay informed about legal and regulatory developments that impact your business.
Client Insight

The DOJ’s New White-Collar Agenda: Implications for Businesses
On May 12, 2025, the Department of Justice (the “DOJ”) released its criminal—and, more specifically, white collar crime enforcement—initiatives under the current administration. This is typical each time new leadership assumes control of the DOJ, and below is a summary of key changes clients should expect in the coming years. Although the Trump administration has…
Read moreClient Insight

AI Meets TCPA: Navigating Business Compliance Risks in Phone Communications
As artificial intelligence continues to transform business communications, companies will continue to face significant—and in some cases, increased—legal risks under the Telephone Consumer Protection Act (TCPA) when choosing to utilize AI-powered calling and messaging technologies. The Federal Communications Commission’s (FCC) recent regulatory actions in the past year confirm that AI-powered tools are not exempt from…
Read moreClient Insight

Deferred Pay at Risk: The Hidden Dangers of Rabbi Trusts
News that Steward Health Care executives may lose millions in unqualified retirement savings due to the company’s use of a “rabbi trust” has sent a jolt through the ranks of corporate leadership. Steward’s deferred compensation plan—intended to provide financial security for its top employees—has instead become a cautionary tale of how quickly that security can…
Read more